Stocks to Buy

Whether you are a novice who just opened your first 401k or you are a seasoned investor, you have to spend countless hours researching stocks to buy. Who has that kind of time? We do. Powered by a diverse group of perspectives formed from dozens of analysts, advisors and strategists, our stories digest the day’s biggest headlines to uncover which stocks you should buy.

Utility Stocks Are About To Pull Back — Get Ready To Buy (SO, ETR)

While year-to-date utility stocks have knocked it out of the park, a recent pullback sets the stage for a chance to buy these stocks at bargains

7 Insurance Stocks to Buy Now

The grades of 7 Insurance stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an "A" ("strong buy") or "B" overall ("buy") rating.

6 Machinery Stocks to Buy Now

The grades of 6 Machinery stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

4 Specialty Retail Stocks to Buy Now

This week, 4 Specialty Retail stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Bank of America Corp (BAC) Is Still a Huge Buy

BAC stock has been rallying for two months now and analysts' are falling in love.

5 Stocks With Prime Earnings Momentum — MNI CRK LEU NRP APA

This week, these five stocks have the best ratings in Earnings Momentum, one of the eight Fundamental Categories on Portfolio Grader.

3 Brazil Stocks to Buy Now for Post-Olympic Gains

Some Brazil stocks aren't in as bad shape as you might think. Ambev (ABEV), BRF (BRFS) and BrasilAgro (LND) stock are three you should consider.

Amazon.com, Inc. (AMZN) Brings Its Ecosystem Model to Music

The power of Amazon (AMZN) is in its ability to create ecosystems around its products -- first books, video and merchant fulfillment, now music.

5 Personal Products Stocks to Buy Now

This week, 5 Personal Products stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Why Twitter Inc (TWTR) Will Finally Get Bought Out

Twitter stock is down 70% in less than three years, TWTR has a wad of cash in the bank and Twitter has more than 300 million MAUs. Twitter has value to someone.

6 Food Products Stocks to Buy Now

The grades of 6 Food Products stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

5 Trading Companies & Distributors Stocks to Buy Now

This week, 5 Trading Companies & Distributors stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

Square Inc (SQ) Is Turning Heads Again

Square stock went from cold to hot, as price flexibility and a profitable loan program have made SQ a buy again.

4 Thrifts & Mortgage Finance Stocks to Buy Now

4 Thrifts & Mortgage Finance stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

5 Stocks With Prime Free Cash Flow — SAEX PACD CDOR BZH CREG

This week, these five stocks have the best ratings in Free Cash Flow, one of the eight Fundamental Categories on Portfolio Grader.

5 Stocks With Prime Earnings Growth — CVCY LRCX CCMP BDC DRE

This week, these five stocks have the best ratings in Earnings Growth, one of the eight Fundamental Categories on Portfolio Grader.

Starbucks Corporation (SBUX) Is as Big a Buy as Ever

Shares in Starbucks (NASDAQ:SBUX) are having a disappointing year but long-term investors have seen this before.

Is Microsoft Corporation (MSFT) the Next Apple?

MSFT beat Apple to the cloud, and the Surface Pro 4 is a hit. If CEO Satya Nadella can resurrect the PC business, Microsoft stock could soar.

Pfizer Inc. (PFE) Adds Oncology Muscle With Medivation Inc (MDVN)

Whether Pfizer (PFE) splits up or not, its growing footprint in blockbuster cancer drugs promises more outperformance to come.